RNU6-92P

Across TCGA pan-cancer cohorts, RNU6-92P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-92P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-92P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-92P expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

STAD, DLBC, and OV are the cancer types where RNU6-92P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.164	0.392	.011	66	view →
DLBC	DFS	Tertile	All	0.068	0.648	<.001	39	view →
OV	OS	Tertile	II,III,IV	0.497	0.697	.005	36	view →
LUSC	OS	Tertile	III,IV	0.264	0.693	.006	36	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	24	view →
GBM	OS	Tertile	All	0.604	0.384	.024	18	view →
ACC	OS	Tertile	III,IV	0.255	0.612	.030	9	view →
LIHC	DFS	Tertile	III,IV	0.121	0.422	.034	9	view →
LGG	OS	Tertile	All	0.315	0.454	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-92P–STAD (DFS)

Open the STAD breakdown →